用不动化的微生物来导出一种扩展模型来生产利醇
Rolando Zenteno-Catemaxca1, Roel Hernandez-Rodriguez2, Epifanio Morales-Zárate1
1Facultad de Ciencias Químicas, Universidad Veracruzana, Xalapa, Mexico.
Biotechnology and bioengineering
|February 17, 2025
概括
这项研究引入了新的宏观模型,用于使用固定微生物生产利醇. 这些模型准确地捕捉了粒子微观结构和生物膜形成,改善了过程模拟和优化.
科学领域:
- 生物化学工程 生物化学工程
- 化学过程建模 化学过程建模
- 生物技术是生物技术.
背景情况:
- 利醇是一种有价值的多醇,越来越多地通过使用固定微生物的生化途径产生.
- 目前用于利醇生产的宏观模型缺乏对粒子微观结构和生物膜形成的详细考虑.
- 优化操作条件和了解大规模运输对于高效的西利生物合成至关重要.
研究的目的:
- 推导出新型的宏观模型,用于利醇生产,并结合固定微生物的微观结构细节.
- 通过考虑多孔粒子内生物膜的形成来提高过程建模的准确性.
- 增强对利醇生物合成中的质量运输和反应动力学的理解.
主要方法:
- 从使用体积平均计算的微观模型中推导出两个宏观模型 (一式和二式方程).
- 通过解决二维单元细胞中的辅助问题来预测有效的介质系数,以代表粒子微观结构.
- 通过拟合实验数据和对孔尺度模拟和实验室规模实验进行模型验证来估计动力参数.
主要成果:
- 开发的宏观模型准确地预测了甘包中糖醇的产量.
- 模型包含微结构信息,与现有方法相比,提供了改进的模拟.
- 导出的有效系数不依赖于经验相关性,增强了模型的概括性.
结论:
- 新的宏观模型提供了一个更准确的象征用固定微生物的利醇生产过程.
- 对粒子微观结构和生物膜形成的计算对于精确的过程建模至关重要.
- 这项工作为优化西利生物合成和相关生物过程提供了基础.
相关概念视频
01:22Bioreactor Controls-III
70
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
70
01:14Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
01:27Upstream Processing
102
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
102
01:25Production of Organic Acids
111
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
111
01:27Production of Antibiotics
281
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
281
01:30Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99